Table 3 Parameters used in the model
From: Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Baseline scenario | Range for sensitivity analysis | Source | |
|---|---|---|---|
Efficacy for the first year following vaccination (%) | |||
Medical visits | 87.7 | (76.2–93.7) | Vesikari T, et al, 2007 |
Hospital admissions | 96.3 | (91.1–98.5) | Vesikari T, et al, 2007 |
Efficacy for the second year following vaccination (%) | |||
Medical visits | 73.8 | (11.5–95.7) | Vesikari T, et al, 2007 |
Hospital admissions | 86.9 | (10.8–99.7) | Vesikari T, et al, 2007 |
Prevalence of G1–G4 serotypes (%) | 90.0 | (83–97) | Mota-Hernandez, et al, 2003 |
Cost per medical visit) 2006 dollars) | 35.85 | (34.59–37.29) | Nafate, 2005 |
Cost per hospital day (2006 dollars) | 222.55 | (215.13–229.97) | Nafate, 2005 |
Cost of the vaccine per dose (2006 dollars) | 10.00 | ||
Cost of administration for the whole schedule (2006 dollars) | 13.77 | ||
Discount rate | 3% | ||
Life expectancy in years at age: | |||
0 years | 70.38 | ‡ | |
1 years | 71.95 | ‡ | |
2 years | 71.74 | ‡ | |
3 years | 70.84 | ‡ | |
4 years | 69.91 | ‡ |